|
Achillion raises $51.8m in IPO.(Friday, Oct. 27), October 30, 2006 |
|
Idenix's Tyzeka receives approval for hepatitis B.(Friday, Oct. 27), October 30, 2006 |
|
Renovis plummets on NXY-059 Phase III miss.(Friday, Oct. 27), October 30, 2006 |
|
Cadence IPO nets $48.5m for two Phase III drugs.(Tuesday, Oct. 26), October 30, 2006 |
|
Forbes Medi-Tech expanding pipeline.(Tuesday, Oct. 26), October 30, 2006 |